Insider information

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors > Insider information

Insider information

03. October 2018

Epigenomics AG plans to increase share capital with subscription rights for existing shareholders / Commitment of major shareholder to participate in planned capital increase

Read more

09. June 2018

Centers for Medicare & Medicaid Services publish preliminary rate of $192 for Epigenomics’ colorectal cancer screening test Epi proColon®

Read more

30. May 2018

Epigenomics AG: American Cancer Society published its updated colorectal cancer screening guidelines

Read more

Press releases

19. December 2018

Centers for Medicare & Medicaid Services issue official 2019 Clinical Lab Fee Schedule including Epi proColon®

Read more

07. November 2018

Epigenomics AG Announces 2018 Third Quarter and Nine Months Financial Results

Read more

31. October 2018

Epigenomics AG Announces Veterans Administration’s Adherence Study using Epi proColon® Colorectal Cancer Screening Blood Test

Read more